Braeburn’s BRIXADI Shows Promise Against Fentanyl in Opioid Use Disorder Study
PLYMOUTH MEETING, PA — Braeburn Inc. has announced the recent tpublication of a post hoc analysis in JAMA Network Open, revealing promising results for its drug BRIXADI in the fight …
Braeburn’s BRIXADI Shows Promise Against Fentanyl in Opioid Use Disorder Study Read More